Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease
Authors:
- Márcia Séllos-MouraMSMárcia Séllos-Moura
- Samad BarzegarSBSamad Barzegar
- Luying PanLPLuying Pan
- Philip ShiPSPhilip Shi
- Susan OommenSOSusan Oommen
- Judith DurantJDJudith Durant
- Juan A. RuizJRJuan A. Ruiz
Open Access
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 373 (1-2) , 45-53
Abstract
No abstract availableKeywords
Funding Information
- Shire Human Genetic Therapies, Inc.
This publication has 15 references indexed in Scilit:
- Characterization of gene-activated human acid- -glucosidase: Crystal structure, glycan composition, and internalization into macrophagesGlycobiology, 2009
- Detection of High- and Low-Affinity Antibodies Against a Human Monoclonal Antibody Using Various Technology PlatformsASSAY and Drug Development Technologies, 2007
- The long-term international safety experience of imiglucerase therapy for Gaucher diseaseMolecular Genetics and Metabolism, 2007
- When biotech proteins go off-patentTrends in Biotechnology, 2004
- Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsJournal of Immunological Methods, 2004
- Development of an animal–human antibody complex for use as a control in ELISAJournal of Pharmaceutical and Biomedical Analysis, 2003
- Enzyme therapy of gaucher disease: clinical and biochemical changes during production of and tolerization for neutralizing antibodies☆ ☆This study was supported by NIH Grant R01 DK 36729 to GAG.Blood Cells, Molecules, and Diseases, 2003
- Management of Neutralizing Antibody to Ceredase in a Patient With Type 3 Gaucher DiseasePediatrics, 1997
- Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant SourcesAnnals of Internal Medicine, 1995
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991